April 25, 2023
Investors in Chembio Diagnostics Inc., a company that sold now-revoked COVID-19 tests, have asked a New York federal court to give a final OK to an $8.1 million deal to end a lawsuit alleging that shareholders were harmed when the company's tests were taken off the market after being deemed ineffective by the U.S. Food and Drug Administration.
August 18, 2020
Lowenstein Sandler LLP and Robbins Geller Rudman & Dowd LLP appear to be leading the fight to helm a putative securities class action against a diagnostics company that had its COVID-19 antibody test revoked by the U.S. Food and Drug Administration.
June 19, 2020
Chembio Diagnostics Inc., a point-of-care diagnostics company that saw its stock price explode in the early stages of the coronavirus pandemic, was sued Thursday after authorization for its COVID-19 antibody test was revoked by the U.S. Food and Drug Administration.